FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device

News from FineHeart !

FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the first fully Intra-Ventricular Flow Accelerator synchronized to the native heartbeat to restore natural heart pumping capacity.

Check out the link : https://cardiology2.com/fineheart-completes-first-successful-chronic-in-...